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Abstract 
Background:  Postural instability is a common motor feature in people with Parkinson's 
disease (PD) together with non-motor features such as cognitive dysfunction. Management of 
postural instability is challenging as it is often resistant to dopaminergic therapy. Greater 
knowledge of postural control is essential to understand postural instability in PD.  
Research Question:  This study aimed to answer how postural control differs in people with 
PD compared to healthy older adults (HOA). Additionally, postural control changes over a 36 
month period and its relationship to cognitive impairment and motor scores were 
investigated.   
Methods:  The study group consisted of 50 people diagnosed with PD and 59 HOAs, 
recruited as part of an incident cohort study (ICICLE-GAIT). Participants stood still for 2 
minutes, eyes open and arms by their side. A single tri-axial accelerometer (Axivity AX3, 
York, UK) on the lower back recorded acceleration. Measurements were taken at 18, 36 and 
54 months after recruitment.  Sample entropy (SampEn), which measures signal 
predictability, was determined for the accelerometry data.   Cognitive tests included the 
Montreal Cognitive Assessment and the Unified Parkinson’s Disease Rating Scale (UPDRS 
III) quantified motor function. Linear mixed models, regression analysis and correlation 
analysis were applied to the data. 
Results:  Results indicated that SampEn was greater for the PD group at all three time-points 
and along all three axes. However, there was no increase of SampEn with disease 
progression.  Higher SampEn values were associated with greater cognitive impairment and 
lower UPDRS III, although correlations were weak. There was a difference between axial 
directions and cognitive and motor scores. 
Significance:  People with PD exhibit decreased regularity of trunk dynamics when standing 
compared to HOAs. Nonlinear accelerometer metrics along all three axes are therefore a 
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potential biomarker of PD. The relationship between trunk dynamics and cognitive function 
indicates common neural pathways. 
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INTRODUCTION 
Parkinson’s disease (PD) is the  second most common neurodegenerative disease with a 
worldwide prevalence greater than 1% in adults over 70 [1].  Early motor symptoms include 
rigidity, bradykinesia, tremor and gait impairment with postural instability emerging as the 
disease progresses [2].  Postural instability is a known predictor of falls with consequential 
impact on wellbeing  [3]. Over 20% of people with PD have also been reported to have  mild 
cognitive impairment (MCI) at initial diagnosis [4].  Changes in cognitive function are 
associated with postural instability [5, 6] and with an increased risk of falls [7, 8]. A 
neuroimaging study supports the link between cognitive function and falling in PD with 
reduced grey matter reported in the  posterior caudate (associated with cognitive function) in 
fallers compared to fallers [8].  Management of postural instability is challenging as it is often 
resistant to dopaminergic therapy [9]. Nonpharmaceutical interventions include different 
treadmill training protocols which show limited improvements in gait and balance [10, 11].   
Clinically, assessment  of postural instability is the Pull test, included in the Unified 
Parkinson’s Disease Rating Scale (UPDRS III), which is insensitive to small changes in 
postural stability [12]. Objectively,  postural stability has been assessed through centre of 
pressure (COP) parameters recorded from a force platform [13] and more recently, from 
body-worn monitors such as accelerometers [14-16]. The derived postural parameters are 
generally linear, providing information about signal characteristics averaged across time.  
However, as postural stability is a function of postural control, parameters that reflect 
underlying neural control mechanisms may yield additional information. For example, people 
with PD have reduced automatic control and  greater conscious control of posture [17, 18].  
This altered regulatory mechanism may present as a change in regularity or predictability of 
postural parameters.  
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The purpose of this study was to investigate predictability of postural trunk dynamics through 
nonlinear analysis of tri-axial accelerometer signals. We included vertical accelerometry data 
as postural control operates in three dimensions and changes in perception of the postural 
vertical in older adults have been postulated [19]. We compared postural trunk predictability 
in people with recently diagnosed PD to postural trunk predictability in healthy older adults 
(HOA). Additionally, we investigated changes in this parameter over a 36 month period and 
its relationship to cognitive dysfunction. We hypothesised that (1) Postural trunk 
predictability is different in people with PD due to the loss of automatic control; (2) Postural 
trunk predictability changes over time in people with PD, as a result of increasing loss of 
automatic motor behaviour; (3) Postural trunk predictability is correlated with clinical 
measures of cognitive dysfunction, reflecting common dysfunctional neural pathways. This 
analysis may offer information about the underlying postural control mechanisms, its 
application as an early biomarker and as an indicator of disease progression.  
METHODS 
Study design 
This study was approved by the Newcastle and North Tyneside Research Ethics Committee 
(project registration number 09/H0906/82). The study group consisted of 50 people (17 
female) recently diagnosed with PD and 59 HOA (26 female), recruited as part of the 
Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-GAIT (ICICLE-
GAIT) study conducted between June 2009 and December 2011.  Postural and cognitive 
assessments were undertaken at approximately 18 months, 36 months and 54 months after the 
baseline assessment. All participants were monitored for at least two of the three sessions and 
all had an assessment at 54 months to eliminate bias that may arise from the more severely 
impaired participants leaving the study early (Table 1).   
7 
 
Participants 
Participants were excluded if they had any neurological (other than PD), orthopaedic or 
cardiothoracic conditions that may have markedly affected their walking or safety during the 
testing sessions. Diagnosis of idiopathic PD was made according to the UK Parkinson’s 
Disease Brain Bank criteria.  Exclusion criteria included significant memory impairment 
(Mini Mental State Exam (MMSE) < 24 [6]), dementia with Lewy bodies or poor command 
of English. This study was conducted according to the declaration of Helsinki and all 
participants signed an informed consent form prior to testing. 
Demographic and clinical measures 
Age, sex and body mass index (BMI) were recorded for each participant. Cognitive tests 
included the MMSE [20] and also the Montreal Cognitive Assessment (MoCA), which 
discriminates more effectively MCI and dementia in PD [21] .  The UPDRS III was used to 
assess the level of motor dysfunction with values  raging from 0 (no motor symptoms) to 132 
(severe motor symptoms) [22].   
Standing balance test 
Participants were instructed to stand still, with shoes on, hands by their sides, within a 
rectangular area (400 mm wide × 600 mm long), while looking straight ahead for 2 minutes. 
Stance width was not controlled for. The PD participants were tested approximately 1 hour 
after medication intake. 
Equipment 
A single tri-axial accelerometer (Axivity AX3, York, UK) on the lower back recorded 
acceleration at a  sampling rate of 100 Hz [14].  
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Data processing 
The tri-axial accelerometry data were exported to the MATLAB® (R2015a, Mathworks, 
Natick, MA) environment, downsampled to 10 Hz and rotated using the Moe-Nilssen 
transformation into anteroposterior, mediolateral and vertical accelerations [14, 23]. No 
filtering was applied. A nonlinear method that quantifies predictability is sample entropy 
(SampEn), defined as the logarithmic probability that two sequences, similar for m points 
extracted from a  time-series, will remain similar at a sequence length of m + 1 [24].  Higher 
values of SampEn indicate low predictability whereas lower values indicate high 
predictability. SampEn was calculated for accelerations along the three axes, using the 
method described by Richman and Moorman (2000) [24]. A vector length of 2 and tolerance 
of 0.2 were selected, based on analysis of combinations of different vector lengths (1,2,3,4) 
and tolerances (0.1, 0.15, 0.2, 0.25) [25, 26] (see Supplementary Material Appendix 1).  
Signal nonlinearity was assessed by applying the rank sum test to SampEn values for 
nineteen surrogate signals  generated using the Iterated Amplitude Adjusted Fourier 
Transform (IAAFT) which preserves the power spectrum and linear correlations [27].   
Data analysis 
Only nonlinear signals, those with SampEn less than the surrogate signals’ SampEn, were 
included in the analysis as application of nonlinear methods requires the timeseries to contain 
nonlinear structures. All statistical analyses were performed in SPSS (v21, IBM, Chicago, Il., 
USA), p < 0.05.  Differences in SampEn between groups (i.e., people with PD vs  HOA ) and 
time-point (i.e., 18 months, 36 months and 54 months) were analysed using linear mixed 
models, which models missing data, and regression analysis.  Sidak corrections for multiple 
comparisons were applied to the post hoc analyses. Pearson’s and Spearman’s correlation 
were used to explore associations between SampEn and MoCA, MMSE and UPDRS III.  
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RESULTS  
Demographic and cognitive data  
The age range of participants across the three time-periods was 44.9–92.0 years for the PD 
group and 53.7–90.8 years for the HOA.  The PD group were significantly younger (F1, 
280=10.3, p=0.001).  There was a smaller proportion of females in the PD group compared to 
the HOA group (34% versus 44%), and they had a lower MoCA score (F1, 280=7.3, p=0.007) 
(Table 1). 
Sample entropy  
a) Signal nonlinear characterization 
Figure 1 illustrates representative  20 second tri-axial accelerometer data for a person with 
Parkinson’s and a healthy older adult. The SampEn values  of accelerometry signals along the 
mediolateral and vertical axes were less than SampEn for the surrogate signals for over 80% 
of the signals, indicating nonlinear properties. The percentage of nonlinear signals for 
anteroposterior signals was lower, particularly at 18 months (HOA 63.3% nonlinear, PD 
group 54.8% nonlinear) due to greater noise on the anteroposterior axis associated with the 
physical construction of the accelerometer. A small percentage of signals had a SampEn 
greater than the surrogate SampEn (see Supplementary Material Appendix 2) reflecting the 
statistical nature of the rank-sum test and limited surrogate signals generated. 
b) Group, time and interaction effects on sample entropy   
 i) Group 
SampEn was greater for the PD group compared to the HOA along all three axes and all three 
time-points (anteroposterior: F1, 101=15.2, p<0.001; mediolateral: F1, 99=18.3, p<0.001; 
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vertical, F1, 103=16.0, p<0.001) (Figure 2). The SampEn in the anteroposterior direction was 
significantly less (F2, 477=62.0, p<0.001) than in the mediolateral and vertical directions. 
ii) Time-period 
Time was significant for SampEn (F2, 139=3.08, p=0.049) in the anteroposterior direction. 
Pairwise comparisons were tending to significance (p=0.055) between 18 months and 54 
months across groups with SampEn decreasing between these time-points (Figure 2). 
Regression analysis showed a significant decrease with time (p=0.009) for SampEn in the 
anteroposterior direction only with no difference in decline between groups. 
iii) Interaction between group and time-point. 
No significant interaction effects were found for group and time-point along any axes, 
indicating no difference in pattern of temporal change in SampEn between the groups.  
c) Association between sample entropy and clinical measures  
All Pearson’s correlation coefficients and Spearman’s rho had a magnitude below 0.3, The 
MoCA, MMSE and UPDRS III are semi-quantitative in nature [28] and have a ceiling effect  
which may account for the weak correlations in addition to the heterogenous nature of the PD 
group.  We therefore report on weak correlations, r>0.2.  
 i) Cognitive clinical scores 
There was a weak negative correlation between SampEn and both MoCA and MMSE scores 
along the anteroposterior and vertical axes at 54 months (Table 2, Figure 3), with better 
cognitive function associated with lower SampEn. Additionally, SampEn in the vertical 
direction was negatively correlated at 36 months with cognitive scores (Table 2, Figure 3).  
There was no correlation greater than 0.2  between SampEn in the mediolateral direction and 
cognitive measures for any time-point (Table 2). 
ii) Motor Clinical Score (UPDRS III) 
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SampEn along all 3 axes showed  positive correlations with UPDRS III, although at differing 
time-points (Table 2, Figure 3). Mediolateral and vertical SampEn had the strongest 
association with UPDRS III, with positive correlations at 18 months (mediolateral: r = 0.218, 
vertical: r = 0.200) and 36 months (mediolateral: r = 0.281, vertical: r = 0.281), indicating 
better motor function is related to lower SampEn. 
DISCUSSION 
This study investigated three dimensional postural dynamics in people with PD and HOA 
over a 36 month period, through SampEn analysis of trunk accelerometry signals. Trunk 
acceleration is less predictable in people with PD when standing, suggesting less constrained 
regulation of posture is associated with reduced automatic control, confirming our first 
hypothesis.  We did not observe any progression of postural movement unpredictability with 
time in the people with PD, contrary to our second hypothesis. Instead, we observed that both 
people with PD and HOA develop more predictable patterns of postural movement over a 
thirty-six month period along the anteroposterior axis. We found weak positive correlations 
between postural movement predictability and clinical motor function and weak negative 
correlation between postural movement predictability and cognitive scores,  partially 
supporting our third hypothesis. 
Lower predictability of postural movements in people with PD.  SampEn was greater along 
all three axes in people with PD compared to older adults, indicating greater unpredictability 
of postural movement. No previous study, to the best of the authors’ knowledge, has 
examined nonlinear analysis of accelerometry signals during standing in people with PD. 
Results from nonlinear analysis of postural COP signals in people with PD are inconsistent.  
Pelykh et al. (2015) reported no difference in the temporal structure of the resultant COP 
signal between people with PD (non-freezers) and a control group [29]. Although trunk 
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accelerometer and COP measures are correlated, it is not known if the same holds for 
nonlinear measures and therefore how valid comparisons are [30].   
Nonlinear analysis of postural accelerometer signals has been undertaken in non-PD 
populations. Lamoth et al. (2012) reported that SampEn for postural accelerometer signals 
was higher for older adult ice-skaters than non-skating older adults and similar to young 
adults [31]. They concluded that the greater postural unpredictability in older adult skaters 
represents greater signal complexity and improved ability to respond to perturbations.  In our 
study, we have observed that SampEn is greater in people with PD indicating less 
predictability. However, SampEn does not provide a measure of complexity as random 
signals have higher SampEn [32] .  
The increased SampEn in the people with PD indicates altered postural motor control which 
may be explained by impairment of neural pathways associated with sensorimotor integration 
and cortical regions involved with habitual control of movement [33]. This neural 
dysfunction will impact the closed-loop system of postural motor control with diminished 
fine adjustments in response to internal and external sensory changes resulting in greater 
irregularity in postural movements.  This explanation is supported by a study investigating 
finger pressures in people with PD when compressing a spring.  Nonlinear attractor 
reconstruction was applied to the pressures and weaker attractors and more chaotic phase 
portraits were found in people with PD compared to older adults suggesting impairment of 
closed-loop motor control [34]. 
Temporal changes in sample entropy. The time-period was significant only for SampEn in 
the anteroposterior direction across both groups, with a decrease tending to significance 
between 18 months and 54 months. These findings are similar to a study investigating 
accelerometry linear metrics over a 12 month period in HOA and people with PD [15].  This 
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suggests that adaptive postural control mechanisms are already well integrated in PD at 18 
months and further change over time follows the normal ageing process, with increased 
predictability of trunk dynamics. The challenge is to find at what stage the temporal structure 
of the postural signal in PD starts to diverge from that of the HOA.   
Cognition and sample entropy. We observed weak negative correlations between SampEn 
and cognitive measures, supporting our third hypothesis.  Although the MMSE is less 
sensitive for mild cognitive impairment than MoCA as [35], both showed negative 
correlations at 36 months and 54 months. No correlation was observed at 18 months, 
probably due to high cognitive function and the ceiling effect of the tests (Table 1). The 
correlation between SampEn and cognition was only present for the anteroposterior and 
vertical components. The relationship may be interpreted either as independent parallel 
declines in postural or cognitive function or deterioration in neural pathways common to both 
motor and cognitive function. Further neuroimaging studies are needed to clarify the 
association.   
Lower postural predictability is associated with greater movement impairment.  SampEn 
correlated positively although weakly, with the UPDRS III, indicating lower postural 
predictability is associated with greater movement impairment.  This finding is surprising as 
the UPDRS III contains only one test, the Pull test,  that relates directly to postural instability 
[12].  The positive association suggests that temporal structure of postural movement is an 
indicator of more general motor control function.  A previous study reported no correlation 
between linear acceleration parameters (e.g. jerk) and UPDRS III [16]. However, none of the 
patients in Mancini et al.’s study were on dopaminergic or other antiparkinsonian treatment, 
whereas in our study all patients were on medication. Levodopa has been reported to increase 
postural sway [36]. Correlation analysis between levodopa equivalent dose (LEDD) and 
SampEn revealed negative correlation at the 18 months time-point (anteroposterior SampEn, 
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r = -0.364; mediolateral SampEn,  r = -0.244; vertical SampEn, r = -0.244). Variations in 
patients’ medication in addition to the different parameters assessed may explain the 
conflicting results.  Changes in dosage and responsiveness to dopaminergic medication may 
account for the increase followed by decrease in SampEn over 36 months (Figure 2).  
Direction of postural control is differentially associated with cognitive and motor function. 
Vertical acceleration SampEn had the most correlations with both cognitive function and 
motor function. Postural control when standing places less constraint on vertical movement 
compared to anteroposterior and mediolateral movement as balance is less affected by 
vertical movement. Control of vertical acceleration may be related more to goal directed 
postural control involving the prefrontal cortex rather than habitual control, with 
consequential greater links to cognitive function. The association of vertical SampEn with the 
clinical motor score can be explained by the more complex neural control strategy employed 
in vertical acceleration of the trunk, with a greater number of muscles activated and joints 
involved. The association between  mediolateral SampEn and motor function is supported by 
another study which reported that mediolateral sway measures are more sensitive at detecting 
differences in sway than anteroposterior measures [15]. Sensorimotor integration is 
differentially affected leading to diverse ankle and hip/trunk strategies with hip/trunk strategy 
more associated with lateral sway [37]. An additional explanation is that people with PD have 
a smaller stance width which is likely to result in greater ML movement [38, 39]. A negative 
weak correlation was found between SampEn in the anteroposterior direction and cognitive 
function. Riley et al. reported a similar link between postural nonlinear measures in the 
anteroposterior direction and cognitive tasks  but not the mediolateral direction [40]. 
Limitations. 
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This study has several limitations. We investigated a small number of people with PD 
presenting with diverse phenotypes who received different types and dosages of medication.  
They also varied in extent of postural impairment and level of cognitive function.  Many of 
the older and PD participants had additional co-morbidities, such as low back pain or lower 
limb joint degeneration that may account for some of the differences in trunk acceleration. 
Stance width was not controlled for, which might have affected acceleration. Another 
limitation is that not all participants were present for all three sessions. However, we applied 
the linear mixed model which models the missing data.  A further limitation is that several 
signals we included as deterministic, may have been identified as nondeterministic if we had 
increased the number of surrogates. The MoCA, MMSE and UPDRS III scores are semi-
quantitative and have a ceiling effect  which may account for the weak correlations we found.  
 CONCLUSION 
Sample entropy of postural acceleration provides a sensitive measure to distinguish people 
with PD from HOA. However, it does not monitor progression of PD. A novel finding is the 
association of postural control in the anteroposterior and vertical directions with cognitive 
function and mediolateral direction with motor function.  Further studies will determine how 
these nonlinear parameters relate to underlying neural correlates and clinical function.  
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Figure 1. Unfiltered trunk accelerometer signals at 18 month timepoint along anteroposterior, 
mediolateral and vertical axes during 20 seconds of standing for: A) Healthy older adult; B) 
Person with Parkinson’s disease.  
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Figure 2.  Changes in sample entropy at 18 months, 36 months and 54 months for 
acceleration signals in the anteroposterior, mediolateral and vertical axes.   * p < 0.05 
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Figure 3. Scatter-plots illustrating the relationship of clinical cognitive scores and clinical motor scores 
(Y) against the vertical acceleration signals (X). Regression lines are included with solid lines showing 
|r| > 0.20, dashed lines |r| < 0.20. 
 
MoCA - Montreal Cognitive Assessment, MMSE –Mini-Mental State Examination, UPDRS III – 
Unified Parkinson’s Disease Rating Scale motor examination. 
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Table 1. Demographics, cognitive and motor scores of healthy older adults (HOA) and people 
with Parkinson’s disease (PD). 
 
 
 
 
 
 
 
 
Time-period 
(months) 
 Group N BMI Age Gender MoCA MMSE UPDRS III 
18  HOA 49 28.5 (3.8) 69.7 (7.5) 25(f) 27.7 (2.5) 28.5 (1.6) n/a 
 PD 42 27.2 (4.2) 66.8 (9.4) 14(f) 26.7 (2.9) 28.3 (1.7) 29.3 (8.5) 
36  HOA 53 28.2 (3.8) 71.1 (7.1) 20(f) 27.7 (2.4)* 28.8 (2.2) n/a 
 PD 39 26.9 (4.7) 68.1 (8.6) 14(f) 26.4 (3.2)* 28.3 (1.9) 36.7 (12.6) 
54  HOA 59 27.9 (3.7) 72.7 (7.6)* 26(f) 26.2 (3.6) 28.6 (1.9)* n/a 
 PD 50 26.8 (4.8) 69.0 (9.6)* 17(f) 25.6 (3.7) 27.6 (2.2)* 37.8 (13.0) 
BMI – Body Mass Index, MoCA - Montreal Cognitive Assessment, MMSE – Mini-Mental State 
Examination, UPDRS – Unified Parkinson’s Disease Rating Scale, n/a – not applicable. 
* represents significant differences between PD and HOA (p < 0.05). 
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Table 2. Correlations between sample entropy in anteroposterior, mediolateral and vertical 
directions and cognitive and motor scores 
 
MoCA - Montreal Cognitive Assessment; MMSE – Mini-Mental State Examination;  
UPDRS – Unified Parkinson’s Disease Rating Scale.  Bold values indicate significance level 
p < 0.05. 
 
 MoCA MMSE UPDRS III 
Anteroposterior 
Sample entropy 
Spearman’s rho (p) Spearman’s rho (p) Spearman’s rho (p) 
18 months -0.183 (0.202) 0.059 (0.395) -0.092 (0.338) 
36 months -0.004 (0.491) 0.028 (0.441) 0.171 (0.184) 
54 months -0.245 (0.075) -0.249( 0.072) 0.273 (0.053) 
Mediolateral 
Sample entropy 
Spearman’s rho (p) Spearman’s rho (p) Pearson coeff (p) 
18 months -0.098 (0.281) 0.009(0.479) 0.218 (0.098) 
36 months -0.167 (0.177) -0.180 (0.158) 0.281 (0.057) 
54 months -0.183 (0.114) -0.191(0.104) 0.126 (0.205) 
Vertical  
Sample entropy 
Spearman’s rho (p) Spearman’s rho (p) Pearson coeff (p) 
18 months -0.060 (0.361) 0.063 (0.355) 0.200 (0.115) 
36 months -0.235 (0.090) -0.255 (0.073) 0.281 (0.053) 
54 months -0.209 (0.082) -0.196 (0.096) 0.137 (0.183) 
